Raymond James & Associates Brainstorm Cell Therapeutics Inc. Call Options Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
Call Options
2 transactions
Others Institutions Holding BCLI
# of Institutions
12Shares Held
599KCall Options Held
32.9KPut Options Held
7.5K-
Black Rock Inc. New York, NY386KShares$691,6810.0% of portfolio
-
Liberty Wealth Management LLC Oakland, CA22.7KShares$40,5720.01% of portfolio
-
Weaver Consulting Group15.6KShares$27,9650.01% of portfolio
-
S.C. Financial Services, Inc.12.7KShares$22,7070.03% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ10.5KShares$18,8290.0% of portfolio
About BRAINSTORM CELL THERAPEUTICS INC.
- Ticker BCLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,486,200
- Market Cap $65.3M
- Description
- Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...